Main Article Content
Objective: Analyzing the dose regimen of carbapenem antibiotics used in pediatric patients at Can Tho Children’s Hospital.
Objects and methods: retrospective-descriptive study on 140 medical records of patients being treated at departments of Can Tho Children’s Hospital during the period from June 1st, 2020 to
December 31st, 2020.
Results: Regarding the dosage regimen characteristics of meropenem showed that 20.3% and 10.8%
of meropenem’s indications for the dose of meropenem for non-central nervous system infections and meningitis treament was appropriate according to the recommendations. Meanwhile, up to
63.5% of the dose was higher than the recommended dose and 5.5% of the treatment dose was lower than the recommended dose. Regarding imipenem dosage regimen characteristics from the results
showed that 71.2% of the dose of imipenem for the treatment of infections non-central nervous system complied with recommendations according to the literature. However, more than 20% of the recommended dose for patients was lower than recommended dose.
Conclusion: The meropenem dose regimen was consistent with the recommendation was low. The imipenem dose regimen was consistent with the relatively high recommendation.
Antibiotic dose regimen, carbapenem, children.
 Falagas ME, Kasiakou SK, Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections, Clin Infect Dis., 2005; 40(9): 1333-1341.
 Minh NTL, Evaluation of the use of carbapenem antibiotics at Bach Mai hospital, Master in pharmacology Thesis, Hanoi University of Pharmacy, 2013. (in Vietnamese)
 Anh NTT, Analysis of the use of carbapenem antibiotics in the emergency department of Thanh Hoa Children's Hospital, Thesis of a specialist pharmacist at level 1, Hanoi University of Pharmacy, 2017. (in Vietnamese)
 Hien NT, Evaluation of the use of carbapenem antibiotics in patients treated in the intensive care unit of Viet Duc Hospital, Master thesis, Hanoi University of Pharmacy, 2012. (in Vietnamese)
 Gilbert DN, Eliopoulos GM, Chambers HF et al., The Sanford Guide to Antimicrobial Therapy 2016, Antimicrobial Therapy, 2016.
 Elizabeth LA, Jeffery L, Mario T et al., Carbapenem-Resistant Enterobacteriaceae Infections: Results From a Retrospective Series and Implications for the Design of Prospective Clinical Trials, Open Forum Infect Dis., 2017; 4(2): ofx063
 Isabelle K, Fabio ST, Frédérique J et al., Optimizing beta-lactams treatment in critically-ill patients using pharmacokinetics/pharmacodynamics targets: are first conventional doses effective?, Expert Rev Anti Infect Ther., 2017; 15(7): 677-688